Sodium lauryl sulfate safety trials should avoid "artificial" effects induction -- subcmte..
This article was originally published in The Tan Sheet
Executive Summary
SODIUM LAURYL SULFATE SAFETY STUDY METHODS IRRELEVANT TO CONSUMER PRACTICE as it relates to safety, according to Lewis Cancro, Cancro, Inc., Trumbull, Conn. Cancro, a nonvoting industry rep, said at FDA's Dental Product Panel Plaque Subcommittee meeting Dec. 16-17 in Bethesda, Md. that "the wearing of occlusive patches" of SLS to test for safety "really doesn't have relevance to the ways these products are used. Certainly the vast experience with [SLS] in this country and around the world doesn't suggest that it is problematic" with regard to safety concerns.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning